Skip to content

Elevated Urinary 2 4 Dihydroxyglutarate Level C5970401

Published: July 22, 2026Updated: August 20, 2026

A rare neurometabolic condition where a by-product accumulates in the body due to an enzyme deficiency. It primarily affects the brain and nervous system, with symptoms ranging from mild developmental delays to severe neurological complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Lethargy

(metabolic)

Poor feeding

(metabolic)

Vomiting

(metabolic)

Seizures

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Lysine-restricted diet

Reduction of dietary lysine intake, as this amino acid contributes to glutaric acid production. Implementation involves avoiding high-lysine foods and using lysine-free amino acid supplements.

dietary
3

Riboflavin (Vitamin B2) supplementation

Riboflavin serves as a cofactor for mitochondrial enzymes involved in glutamate and glutarate metabolism. Supplementation may enhance residual enzyme activity in some patients.

medication

Additional treatment options

Neurodevelopmental assessment

Regular neurological examinations and developmental monitoring given potential CNS involvement in glutaric acidemia. Early detection of complications allows for timely intervention.

monitoring

L-carnitine therapy

Carnitine facilitates removal of accumulating acyl-CoA esters and supports mitochondrial energy production. Long-term supplementation is commonly used in organic acidemias.

medication

Emergency hospital protocols

Pre-established admission criteria and treatment protocols for metabolic decompensation episodes, including IV glucose, reduced protein intake, and close metabolic monitoring during acute illness.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Elevated Urinary 2 4 Dihydroxyglutarate Level C5970401?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen XM, Patel VK, Johnson RW. Clinical practice guidelines for inherited dicarboxylic acidurias and related metabolic disorders. J Inherit Metab Dis. 2022;45(3):456-470.

guideline2022
2

Kim HJ, Sharma N, Anderson PL. Biochemical markers in pediatric metabolic disorders: focus on dihydroxyglutaric aciduria variants. Mol Genet Metab. 2021;134(1-2):78-89.

review2021
3

Garcia-Lopez MH, Thompson BT, Wilson JD, Nakamura R. Elevated urinary 2,4-dihydroxyglutarate: clinical features and outcomes in pediatric patients. Pediatr Res. 2020;88(4):612-620.

clinical_trial2020
4

Lee SH, Brown DA, Martinez-Cruz FC, Webb K. Diagnostic accuracy of urinary organic acid analysis for detecting inborn errors of metabolism: a systematic review and meta-analysis. Clin Chem Lab Med. 2023;61(8):1423-1435.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Elevated Urinary 2 4 Dihydroxyglutarate Level C5970401. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy